| Off-label use of medications: innovative prescribing or risky business? | |
| | |
MedLine Citation:
|
PMID: 21172761 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Off-label use of medication is common and can lead to innovations in the use of medicine to treat patients in unconventional ways. However, issues of increased health care costs, decreased reimbursement, and lack of clinical data to support off-label use, are concerns of practitioners and patients alike. By using their knowledge of medications and carefully examining the existing research, pharmacists can aid prescribers in appropriate off-label medication use. |
| | |
Authors:
|
Caren McHenry Martin |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists Volume: 25 ISSN: 0888-5109 ISO Abbreviation: Consult Pharm Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-12-21 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9013983 Medline TA: Consult Pharm Country: United States |
Other Details:
|
Languages: eng Pagination: 806-14 Citation Subset: IM |
Affiliation:
|
Greensboro, North Carolina. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Introduction to medication regimen review-part 2.
Next Document: Oral hydromorphone extended-release.